Apolipoprotein CIII is upregulated by anticalcineurins and rapamycin: implications in transplantation-induced dyslipidemia

Transplant Proc. 2000 Dec;32(8):2783-4. doi: 10.1016/s0041-1345(00)01884-4.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Apolipoprotein C-III
  • Apolipoproteins A / blood
  • Apolipoproteins B / blood
  • Apolipoproteins C / blood*
  • Apolipoproteins C / genetics
  • Azathioprine / therapeutic use
  • Calcineurin Inhibitors*
  • Cholesterol / blood
  • Cyclosporine / therapeutic use
  • Humans
  • Hyperlipidemias / blood*
  • Hyperlipidemias / etiology
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation / physiology*
  • Middle Aged
  • Postoperative Complications
  • Reference Values
  • Sirolimus / therapeutic use*
  • Tacrolimus / therapeutic use
  • Triglycerides / blood

Substances

  • Apolipoprotein C-III
  • Apolipoproteins A
  • Apolipoproteins B
  • Apolipoproteins C
  • Calcineurin Inhibitors
  • Immunosuppressive Agents
  • Triglycerides
  • Cyclosporine
  • Cholesterol
  • Azathioprine
  • Sirolimus
  • Tacrolimus